MDB Capital Holdings, LLC (MDBH) is an innovative investment firm dedicated to capitalizing on growth opportunities within the technology and life sciences sectors through strategic capital allocation and tailored advisory services. The firm is guided by a seasoned management team with extensive industry experience, focused on enhancing shareholder value and delivering substantial returns for institutional investors. As a Class A common stock, MDBH is well-positioned to adapt to economic fluctuations while pursuing its mission of fostering innovation and financial integrity, ultimately driving transformative growth in dynamic markets.
| Revenue (TTM) | $4.13M |
| Gross Profit (TTM) | $2.30M |
| EBITDA | — |
| Operating Margin | -12457.00% |
| Return on Equity | -34.70% |
| Return on Assets | -33.90% |
| Revenue/Share (TTM) | $0.41 |
| Book Value | $5.47 |
| Price-to-Book | 0.62 |
| Price-to-Sales (TTM) | 8.59 |
| EV/Revenue | 4.668 |
| EV/EBITDA | 0.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -94.70% |
| Shares Outstanding | $5.44M |
| Float | $4.73M |
| % Insiders | 11.58% |
| % Institutions | 3.46% |
Volatility is currently expanding
Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.
Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1."
PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services
• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes
Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT at the Bellagio Resort & Hotel in Las Vegas, Nevada.
� New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning. · The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.
� Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.
Dallas, TX, April 29, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse: “The Last 20%: Retatrutide, the Glucagon Paradox, and the Race to Own Surgery-Level Weight Loss Without Surgery.”
